Literature DB >> 10800764

From macroprolactinoma to concomitant ACTH-PRL hypersecretion with Cushing's disease.

M Barausse1, R Attanasio, D Dallabonzana, G Oppizzi, S Veronese, G Lasio, L G Valentini, R Cozzi.   

Abstract

Multiple pituitary hormone hypersecretions have been already described, but the combination of PRL and ACTH excess is rare. This report deals with a 42-yr-old woman affected by macroprolactinoma (PRL 12,720 microg/l, huge tumor with extrasellar extension at imaging). After one year on dopaminergic treatment causing PRL normalization and tumor shrinkage, she developed hypercortisolism (UFC 1,000 microg/24 h, ACTH 200 ng/l). Cushing's disease was diagnosed. After neurosurgery (at immunocytochemistry mixed ACTH-PRL adenoma was shown) hypercortisolism remitted, whereas pathological hyperprolactinemia with tumor remnant in cavernous sinus persisted and hypopituitarism developed. The patient reported seems atypical for the following reasons: 1) the concomitant PRL and ACTH hypersecretions; 2) the clinical presentation with hypercortisolism following hyperprolactinemia; 3) the surgical cure of hypercortisolism with persisting hyperprolactinemia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10800764     DOI: 10.1007/BF03343688

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  24 in total

Review 1.  Endocrine investigation: Cushing's syndrome.

Authors:  R J Ross; P J Trainer
Journal:  Clin Endocrinol (Oxf)       Date:  1998-08       Impact factor: 3.478

Review 2.  Dissecting multistep tumorigenesis in transgenic mice.

Authors:  D Hanahan
Journal:  Annu Rev Genet       Date:  1988       Impact factor: 16.830

3.  Effects of methysergide, bromocriptine and naloxone on prolactin, growth hormone and TSH release induced by D-Met2,Pro5-enkephalinamide in man.

Authors:  J Földes; A Váradi; A Gara; C Bános; P Vargha; K Török; J I Székely
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Two-step development of a pituitary adenoma: from hyperprolactinemic syndrome to Cushing's disease.

Authors:  R G Gheri; W Boddi; F Ammannati; J Olivotto; C Nozzoli; A Franchi; L Bordi; M L Luisi; P Mennonna
Journal:  J Endocrinol Invest       Date:  1997-04       Impact factor: 4.256

5.  Coexpression of galanin and adrenocorticotropic hormone in human pituitary and pituitary adenomas.

Authors:  D W Hsu; S C Hooi; E T Hedley-Whyte; R M Strauss; L M Kaplan
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

6.  Cushing's disease presenting as amenorrhoea with hyperprolactinaemia: report of two cases.

Authors:  T H Jurney; H de Ruyter; R A Vigersky
Journal:  Clin Endocrinol (Oxf)       Date:  1981-06       Impact factor: 3.478

7.  Enhanced prolactin responsiveness to galanin in patients with Cushing's disease.

Authors:  C Invitti; F Pecori Giraldi; A Tagliaferri; M Scacchi; A Dubini; F Cavagnini
Journal:  Clin Endocrinol (Oxf)       Date:  1993-08       Impact factor: 3.478

8.  Involvement of brain dopamine in prolactin secretion induced by a synthetic Met5-enkephalin analogue in rats.

Authors:  N Matsushita; Y Kato; H Katakami; A Shimatsu; H Imura
Journal:  Endocrinol Jpn       Date:  1982-06

9.  Clonal origin of pituitary adenomas.

Authors:  V Herman; J Fagin; R Gonsky; K Kovacs; S Melmed
Journal:  J Clin Endocrinol Metab       Date:  1990-12       Impact factor: 5.958

10.  Amenorrhea-galactorrhea associated with Cushing's disease due to pituitary tumor.

Authors:  S Rodriguez; M Alger; G Forsbach; S N Contreras; E S Canales; A Zarate
Journal:  J Endocrinol Invest       Date:  1981 Jan-Mar       Impact factor: 4.256

View more
  4 in total

1.  Hyperprolactinemia preceding Cushing's disease.

Authors:  L Barbetta; C Dall'Asta; B Ambrosi
Journal:  J Endocrinol Invest       Date:  2000 Jul-Aug       Impact factor: 4.256

2.  Dopamine agonist-responsive Cushing's disease.

Authors:  Gurpreet Anand; Andrea Bink; Felix Beuschlein; Christoph Schmid
Journal:  BMJ Case Rep       Date:  2019-02-13

3.  Macroprolactinoma associated with Cushing's disease, successfully treated with cabergoline.

Authors:  G T'Sjoen; I Defeyter; J Van De Saffele; R Rubens; M Vandeweghe
Journal:  J Endocrinol Invest       Date:  2002-02       Impact factor: 4.256

4.  Transgenic Mouse Studies to Understand the Regulation, Expression and Function of the Testis-Specific Protein Y-Encoded (TSPY) Gene.

Authors:  Stephanie Schubert; Jörg Schmidtke
Journal:  Genes (Basel)       Date:  2010-08-18       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.